NCT07469397 Preliminary Exploration of Factors Affecting Complete Hemostasis and Supine Time After Removal of Femoral Arterial Sheath in ICU Patients
| NCT ID | NCT07469397 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Removal of Femoral Arterial Sheath in ICU Patients |
| Study Type | OBSERVATIONAL |
| Enrollment | 157 participants |
| Start Date | 2025-05-15 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 157 participants in total. It began in 2025-05-15 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background:Following cardiac catheterization and arterial sheath removal, manual compression is applied until bleeding stops, after which a compression belt is used. Patients must lie supine for at least 6 hours, often experiencing discomfort including back pain, eating difficulties, and urinary problems. The compressed leg is restrained to prevent movement, adding to the discomfort. Despite adhering to this standard procedure, some patients still develop bleeding or hematomas after compression, requiring extended treatment. Current research on predicting compression duration and bleeding risk factors after femoral arterial sheath removal is limited and inconsistent. This study aims to identify factors that can more accurately predict necessary compression time after initial hemostasis, potentially reducing patient discomfort and complications such as prolonged bleeding, extended compression, and hematoma formation, which can impact vital signs. Purpose:To understand the factors influencing complete hemostasis and supine duration after femoral arterial sheath removal in ICU patients. Methods:Clinical data were collected through observation, and statistical analysis was performed using SPSS. Expected Outcomes:To identify factors that influence complete hemostasis and supine duration after femoral arterial sheath removal in ICU patients, and to develop a prediction model that allows clinical units to accurately assess the required supine compression time following femoral arterial sheath removal.
Eligibility Criteria
Inclusion Criteria: 1. Patients admitted to the cardiac intensive care unit of this hospital. 2. Patients undergoing femoral arterial sheath removal. 3. Age 20 years or older. Exclusion Criteria: 1. Patients unable to maintain supine position or refusing physical restraints. 2. Patients with severe hematoma, vascular rupture, or other vascular complications present at the femoral arterial puncture site at the time of sheath insertion. 3. Patients with a diagnosis of severe disseminated intravascular coagulation (DIC).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07469397 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Removal of Femoral Arterial Sheath in ICU Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07469397 currently recruiting?
Yes, NCT07469397 is actively recruiting participants. Contact the research team at unique201001@gmail.com for enrollment information.
Where is the NCT07469397 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT07469397 clinical trial?
NCT07469397 is sponsored by National Taiwan University Hospital. The trial plans to enroll 157 participants.